Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × liposomal doxorubicin × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 11 Breast Neoplasms 9 Triple Negative Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Sarcoma 3 Sarcoma, Kaposi 2 Sarcoma, Ewing 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 AIDS-related Kaposi sarcoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Rhabdomyosarcoma 1 Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Multiple Myeloma 1 Macular dystrophy, corneal type 1 1

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡